CCI Photonics boosted by £100,000 support
A life sciences firm has received £100,000 backing.
CCI Photonics has been supported by LYVA Labs to develop a urinary tract infection test.
Bosses say the apparatus will carry out a 15-minute test before identifying the correct antibiotics for treatment.
They add current methods for testing bacteria causing urinary tract infections can take up to 72 hours.
Dr Carlos Meza, CCI Photonics chief executive, said: “LYVA Labs' investment will help speed up the process of bringing our device to market, strengthen our quality management system as we prepare for regulatory approval, and develop our route-to-market strategy.”
CCI Photonics recently moved to Sci-Tech Daresbury, and has partnered with the Liverpool School of Tropical Medicine to further validate its technology.
It is taking part in the LYVA Labs’ incubator programme.
Akshay Bhatnagar, LYVA Labs’ head of investments, added: “We are excited to support Carlos and the team to develop this game-changing technology with the potential to help urinary tract infection sufferers all over the world and combat the scourge of antimicrobial resistance.”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
£100,000 milestone drives forward STEM work
Restoring confidence for the economic road ahead
Ready to scale? Buy-and-build offers opportunity
When will our regional economy grow?
Creating a thriving North East construction sector
Why investors are still backing the North East
Time to stop risking Britain’s family businesses
A year of growth, collaboration and impact
2000 reasons for North East business positivity
How to make your growth strategy deliver in 2026
Powering a new wave of regional screen indies
A new year and a new outlook for property scene